These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17588547)

  • 61. Lack of effect of a single dose of hydrocortisone on serotonin(1A) receptors in recovered depressed patients measured by positron emission tomography with [11C]WAY-100635.
    Bhagwagar Z; Montgomery AJ; Grasby PM; Cowen PJ
    Biol Psychiatry; 2003 Nov; 54(9):890-5. PubMed ID: 14573316
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduced expression of the glucocorticoid receptor in the hippocampus of patients with drug-resistant temporal lobe epilepsy and comorbid depression.
    D'Alessio L; Mesarosova L; Anink JJ; Kochen S; Solís P; Oddo S; Konopka H; Iyer AM; Mühlebner A; Lucassen PJ; Aronica E; van Vliet EA
    Epilepsia; 2020 Aug; 61(8):1595-1605. PubMed ID: 32652588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epilepsy duration impacts on brain glucose metabolism in temporal lobe epilepsy: results of voxel-based mapping.
    Akman CI; Ichise M; Olsavsky A; Tikofsky RS; Van Heertum RL; Gilliam F
    Epilepsy Behav; 2010 Mar; 17(3):373-80. PubMed ID: 20149754
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic polymorphisms of the serotonin transporter are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis.
    Vincentiis S; Alcantara JA; Rzezak P; Kerr DS; Gattaz WF; van der Linden H; Dos Santos B; Arruda F; Chaim-Avancini T; Serpa MH; Fernandes F; Moreno RA; Busatto GF; Alessi R; Demarque R; Valente KD
    Epilepsy Behav; 2021 Apr; 117():107854. PubMed ID: 33639436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.
    Hirvonen J; Karlsson H; Kajander J; Lepola A; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):465-76. PubMed ID: 17971260
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical FDG-PET Findings in Patients with Temporal Lobe Epilepsy: Concordance with EEG and MRI.
    Jaisani Z; Miletich RS; Ramanathan M; Weinstock AL
    J Neuroimaging; 2020 Jan; 30(1):119-125. PubMed ID: 31661187
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Higher 5-HT
    Milak MS; Pantazatos S; Rashid R; Zanderigo F; DeLorenzo C; Hesselgrave N; Ogden RT; Oquendo MA; Mulhern ST; Miller JM; Burke AK; Parsey RV; Mann JJ
    Psychiatry Res Neuroimaging; 2018 Jun; 276():15-23. PubMed ID: 29702461
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disulfiram inhibits defluorination of (18)F-FCWAY, reduces bone radioactivity, and enhances visualization of radioligand binding to serotonin 5-HT1A receptors in human brain.
    Ryu YH; Liow JS; Zoghbi S; Fujita M; Collins J; Tipre D; Sangare J; Hong J; Pike VW; Innis RB
    J Nucl Med; 2007 Jul; 48(7):1154-61. PubMed ID: 17574977
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy.
    Matheja P; Kuwert T; Lüdemann P; Weckesser M; Kellinghaus C; Schuierer G; Diehl B; Ringelstein EB; Schober O
    Eur J Nucl Med; 2001 May; 28(5):625-32. PubMed ID: 11383869
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders.
    Spindelegger C; Lanzenberger R; Wadsak W; Mien LK; Stein P; Mitterhauser M; Moser U; Holik A; Pezawas L; Kletter K; Kasper S
    Mol Psychiatry; 2009 Nov; 14(11):1040-50. PubMed ID: 18362913
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Altered spontaneous brain activity in MRI-negative refractory temporal lobe epilepsy patients with major depressive disorder: A resting-state fMRI study.
    Zhu X; He Z; Luo C; Qiu X; He S; Peng A; Zhang L; Chen L
    J Neurol Sci; 2018 Mar; 386():29-35. PubMed ID: 29406962
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
    Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
    Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Depression and Temporal Lobe Epilepsy: Expression Pattern of Calbindin Immunoreactivity in Hippocampal Dentate Gyrus of Patients Who Underwent Epilepsy Surgery with and without Comorbid Depression.
    D'Alessio L; Konopka H; Solís P; Scévola L; Lima MF; Nuñez C; Seoane E; Oddo S; Kochen S
    Behav Neurol; 2019; 2019():7396793. PubMed ID: 31191739
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ictal SPECT statistical parametric mapping in temporal lobe epilepsy surgery.
    Kazemi NJ; Worrell GA; Stead SM; Brinkmann BH; Mullan BP; O'Brien TJ; So EL
    Neurology; 2010 Jan; 74(1):70-6. PubMed ID: 20038775
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ictal chronology and interictal spikes predict perfusion patterns in temporal lobe epilepsy: a multivariate study.
    Wichert-Ana L; Velasco TR; Terra-Bustamante VC; Alexandre V; Guarnieri R; Walz R; Kato M; Araújo WM; Carlotti CG; Araújo D; Carlos Dos Santos A; Sakamoto AC
    Seizure; 2004 Jul; 13(5):346-57. PubMed ID: 15158707
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
    Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
    Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lack of aura experience correlates with bitemporal dysfunction in mesial temporal lobe epilepsy.
    Schulz R; Lüders HO; Hoppe M; Jokeit H; Moch A; Tuxhorn I; May T; Ebner A
    Epilepsy Res; 2001 Mar; 43(3):201-10. PubMed ID: 11248532
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of patients with late-onset and medically refractory temporal lobe epilepsy with mesial temporal sclerosis.
    Ayas S; Kurtish SY; Tanrıverdi T; Yeni SN
    Clin Neurol Neurosurg; 2020 Nov; 198():106209. PubMed ID: 32987311
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy.
    Henry TR; Frey KA; Sackellares JC; Gilman S; Koeppe RA; Brunberg JA; Ross DA; Berent S; Young AB; Kuhl DE
    Neurology; 1993 Oct; 43(10):1998-2006. PubMed ID: 8413957
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.